MQS Management LLC acquired a new stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 3,177 shares of the company's stock, valued at approximately $336,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Assetmark Inc. boosted its position in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after acquiring an additional 259 shares in the last quarter. Optiver Holding B.V. purchased a new position in Revvity in the 4th quarter worth approximately $33,000. Quarry LP raised its holdings in Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Revvity during the 4th quarter valued at $38,000. Finally, Vermillion Wealth Management Inc. purchased a new stake in Revvity during the 4th quarter valued at $41,000. 86.65% of the stock is owned by institutional investors.
Revvity Price Performance
Shares of NYSE RVTY traded down $2.86 during trading on Friday, hitting $92.65. The company had a trading volume of 385,428 shares, compared to its average volume of 974,035. The stock has a fifty day simple moving average of $95.06 and a two-hundred day simple moving average of $104.10. Revvity Inc. has a fifty-two week low of $87.70 and a fifty-two week high of $129.50. The firm has a market capitalization of $10.92 billion, a price-to-earnings ratio of 39.52, a price-to-earnings-growth ratio of 2.39 and a beta of 0.98. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41.
Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The business had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same quarter last year, the business earned $0.98 earnings per share. The company's revenue for the quarter was up 2.3% compared to the same quarter last year. On average, research analysts expect that Revvity Inc. will post 4.94 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. Revvity's payout ratio is presently 11.91%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on RVTY. Bank of America cut their price objective on shares of Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Barclays decreased their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Wall Street Zen raised shares of Revvity from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and dropped their target price for the stock from $145.00 to $115.00 in a research note on Thursday, May 1st. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $123.07.
Read Our Latest Stock Report on RVTY
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Further Reading
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
